We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
NUVO - Division of Medical Illumination

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
08 Jun 2023 - 10 Jun 2023

First Endocervical Tissue Sampler for Cervical Cancer Diagnosis Captures Comprehensive 360-Degree Sample

By HospiMedica International staff writers
Posted on 04 May 2023
Print article
Image: FemCerv is the first and only approach for comprehensive tissue sampling for diagnosis of cervical cancer (Photo courtesy of Femasys)
Image: FemCerv is the first and only approach for comprehensive tissue sampling for diagnosis of cervical cancer (Photo courtesy of Femasys)

There is a pressing need for advancements in the current standard of care for diagnosing the presence of cancerous cells in a woman's cervix. When a woman's pap smear yields abnormal results, she usually undergoes a colposcopy, which often involves endocervical curettage or obtaining a tissue sample from the highly sensitive cervical canal. The available tools for collecting this tissue are limited and can cause pain, bleeding, and severe discomfort, as well as produce inadequate or contaminated samples. If sample contamination occurs, additional tests and office visits would be needed to acquire more samples. Now, the first-ever endocervical tissue sampler (curette) designed to collect and secure a comprehensive sample, maximizing quality and quantity, brings much-needed advanced technologies to women.

Femasys Inc.’s (Suwanee, GA, USA) FemCerv, an FDA-cleared endocervical sampler, is the first of its kind, designed to capture a complete and uncontaminated sample through a relatively pain-free procedure. FemCerv features an expandable collection chamber that is exposed during sampling and closed during removal to contain cervical cells and tissue. It can be used alongside colposcopy and aims to capture and preserve a comprehensive 360-degree tissue sample in a relatively pain-free office visit. FemCerv has now also received approval from Health Canada, the Public Health Agency of Canada.

“We are delighted to gain another product approval in Canada, with FemCerv now available to women throughout all of North America as a more advanced alternative for tissue sampling to detect cervical cancer,” said Kathy Lee-Sepsick, Femasys’ founder, president and, chief executive officer.

Related Links:
Femasys Inc. 

Gold Supplier
Temperature Monitor
ThermoScan Temperature Monitoring Unit
New
Ceiling Suspension Tubestand
Lem Plus iC
New
Electric Gynecological Operating Table
YF-6
New
Oxygen Therapy Hyperbaric Chamber
Sechrist 2800

Print article
FIME - Informa

Channels

AI

view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: The novel intravascular, catheter-based technology is designed to treat pulmonary hypertension (Photo courtesy of Freepik)

Minimally Invasive Catheter-Based Technology Treats Pulmonary Hypertension

Pulmonary hypertension, a deadly condition impacting roughly 500,000 patients annually across the world, is currently categorized as a rare disease. As it stands, available treatment options are restricted,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: VCM viscoelastic testing instrument provides rapid, real-time hemostasis assessment at POC (Photo courtesy of Entegrion)

Next Gen Viscoelastic Coagulation Monitor Enables Rapid Hemostasis Assessment at Patient Side

The use of viscoelastic coagulation testing is on the rise for various applications such as trauma, surgery, obstetrics, major disease management, and more. It provides crucial information not obtained... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.